Biosergen AB

Symbol: BIOSGN.ST

STO

0.311

SEK

Market price today

  • -0.9862

    P/E Ratio

  • 0.0300

    PEG Ratio

  • 48.70M

    MRK Cap

  • 0.00%

    DIV Yield

Biosergen AB (BIOSGN-ST) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.00%

Operating Profit Margin

0.00%

Net Profit Margin

0.00%

Return on Assets

-3754.34%

Return on Equity

-3.15%

Return on Capital Employed

-12866.73%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Ms. Tine Kold Olesen Ph.D.
Full-time employees:3
City:Solna
Address:Fogdevreten 2
IPO:2021-06-24
CIK:

Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.

Return on Investments

The company's asset efficiency, represented by a robust -3754.340% return, is a testament to Biosergen AB's adeptness in optimizing resource deployment. Biosergen AB's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -3.153%. Furthermore, the proficiency of Biosergen AB in capital utilization is underscored by a remarkable -12866.730% return on capital employed.

Liquidity Ratios

Analyzing BIOSGN.ST liquidity ratios reveals its financial health of the firm. The current ratio of 141.61% gauges short-term asset coverage for liabilities. The quick ratio (37.03%) assesses immediate liquidity, while the cash ratio (37.03%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio141.61%
Quick Ratio37.03%
Cash Ratio37.03%

Profitability Ratios

The effective tax rate stands at -24.43%, revealing its tax efficiency. The net income per EBT, 99.99%, and the EBT per EBIT, 99.31%, provide insights into its earnings hierarchy.

cards.indicatorcards.value
Effective Tax Rate-24.43%
Net Income per EBT99.99%
EBT per EBIT99.31%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.42, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding37
Days of Payables Outstanding8
Payables Turnover45.67

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.38, and free cash flow per share, -0.38, depict cash generation on a per-share basis.

cards.indicatorcards.value
Operating Cash Flow per Share-0.38
Free Cash Flow per Share-0.38
Free Cash Flow to Operating Cash Flow Ratio1.00

Debt and Leverage Ratios

An interest coverage of 13613.00 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage13613.00
Company Equity Multiplier3.40

Per Share Data

Net income per share, -530.00, reflects the portion of profit attributed to each share. The book value per share, 0.04, represents the net asset value distributed per share, while the tangible book value per share, 0.04, excludes intangible assets.

cards.indicatorcards.value
Net Income Per Share-530.00
Book Value Per Share0.04
Tangible Book Value Per Share0.04
Shareholders Equity Per Share0.04

Growth Ratios

EBIT growth, -1.89%, and operating income growth, -1.89%, offer insights into operational profitability progression. The net income growth, 20.28%, showcases bottom-line expansion, and the EPS growth, 17.19%, measures the growth in earnings per share.

cards.indicatorcards.value
Gross Profit Growth-62.86%
EBIT Growth-1.89%
Operating Income Growth-1.89%
Net Income Growth20.28%
EPS Growth17.19%
EPS Diluted Growth17.19%
Weighted Average Shares Growth-3.32%
Weighted Average Shares Diluted Growth-3.32%
Operating Cash Flow Growth-10.74%
Free Cash Flow Growth-10.74%
10-Year Revenue Growth per Share-100.00%
5-Year Revenue Growth per Share-100.00%
3-Year Revenue Growth per Share-100.00%
10-Year Operating CF Growth per Share-5622.79%
5-Year Operating CF Growth per Share-5622.79%
3-Year Operating CF Growth per Share-2789.39%
10-Year Net Income Growth per Share-1926.47%
5-Year Net Income Growth per Share-1926.47%
3-Year Net Income Growth per Share-1420.88%
10-Year Shareholders Equity Growth per Share283.22%
5-Year Shareholders Equity Growth per Share283.22%
3-Year Shareholders Equity Growth per Share178.69%
Receivables Growth-100.00%
Asset Growth-78.69%
Book Value per Share Growth-90.40%
SGA Expenses Growth-9.84%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 42,243.245, captures the company's total value, considering both debt and equity. Income quality, 1.21, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value42,243.245
Income Quality1.21
Graham Number22.24
Return on Tangible Assets-375461.74%
Graham Net Net-0.06
Working Capital2,116
Tangible Asset Value2,116
Net Current Asset Value2,116
Average Receivables2,010,500
Average Payables3,408,042.5
Days Payables Outstanding4070
ROIC-3755400.39%
ROE-12777.41%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 12599.90, and the price to book ratio, 12599.90, reflect the market's valuation relative to the company's book value. Ratios like price to free cash flows, -1.49, and price to operating cash flows, -0.82, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio12599.90
Price to Book Ratio12599.90
Price Cash Flow Ratio-0.82
Price Earnings to Growth Ratio0.03
Enterprise Value Multiple-2.36
Price Fair Value12599.90
Price to Operating Cash Flow Ratio-0.82
Price to Free Cash Flows Ratio-1.49
Price to Tangible Book Ratio20.85
Enterprise Value Over EBITDA184.47
Earnings Yield-61271.93%
Free Cash Flow Yield-73885.73%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Biosergen AB (BIOSGN.ST) on the STO in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.986 in 2024.

What is the ticker symbol of Biosergen AB stock?

The ticker symbol of Biosergen AB stock is BIOSGN.ST.

What is company IPO date?

IPO date of Biosergen AB is 2021-06-24.

What is company current share price?

Current share price is 0.311 SEK.

What is stock market cap today?

The market cap of stock today is 48696421.000.

What is PEG ratio in 2024?

The current 0.030 is 0.030 in 2024.

What is the number of employees in 2024?

In 2024 the company has 3.